Abstract
Bradykinins are released from kininogen by kallikrein. They increase capillary lung permeability after their binding to β1 and especially β2 receptors before being metabolized by kininase enzyme. This study was performed to evaluate cardiopulmonary damages and inflammatory response on injected rats with Aah I toxin of scorpion venom and the involvement of Kallikrein-Kinin system in this pathogenesis. Obtained results revealed that Aah I toxin induces inflammatory cell infiltration accompanied by cellular peroxidase activities, a release of cytokine levels, pulmonary and myocardial damage, with altered metabolic activities and imbalanced redox status. Administration of aprotinin (bradykinin inhibitor) and especially icatibant (bradykinin β2 receptor antagonist) seemed to be able to protect animals against the toxicity of Aah I; nevertheless, the use of captopril (kininase II inhibitor) reduced partially some cardiac disorders. These findings indicate that the kallikrein-kinin system may contribute to the physiopathological effect and lung edema formation induced by toxin, which suggests a potential use of drugs with significant anti-kinin properties.
Similar content being viewed by others
Abbreviations
- Aah:
-
Androctonus australis hector
- Aah I:
-
Neurotoxins purified from Aah venom
- ACE:
-
Angiotensin-converting enzyme
- ACEI:
-
Angiotensin-converting enzyme inhibitor
- Apro:
-
Aprotinine
- Cap:
-
Captopril
- Icati:
-
lcatibant
- IL-1β:
-
Cytokines: Interleukin-1β
- IL-6:
-
Interleukin-6
- I-10:
-
Interleukin-10
- MDA:
-
Malondialdehyde
References
Ismail, M. 1995. The scorpion envenoming syndrome. Toxicon 33: 825–858.
Rochat, H., P. Bernard, and F. Couraud. 1979. Scorpion toxins: chemistry and mode of action. Advances in Cytopharmacology 3: 325–334.
Couraud, F., E. Jover, J.M. Dubois, and H. Rochat. 1982. Two types of scorpion receptor sites, one related to the activation, the other to the inactivation of the action potential sodium channel. Toxicon 20: 9–16.
Devaux, C., B. Jouirou, Krifi M. Naceur, O. Clot-Faybesse, M. El Ayeb, and H. Rochat. 2004. Quantitative variability in the biodistribution and in toxinokinetic studies of the three main alpha toxins from the Androctonus australis hector scorpion venom. Toxicon 43: 661–669.
Amaral, C.F., J.A. Lopes, R.A. Magalhaes, and N.A. de Rezende. 1991. Electrocardiographic, enzymatic and echocardiographic evidence of myocardial damage after Tityus serrulatus scorpion poisoning. American Journal of Cardiology 67: 655–657.
Rahav, G., and A.T. Weiss. 1990. Scorpion sting-induced pulmonary edema. Scintigraphic evidence of cardiac dysfunction. Chest 97: 1478–1480.
Freire-Maia, L., and I.M. de Matos. 1993. Heparin or a PAF antagonist (BN-52021) prevents the acute pulmonary edema induced by Tityus serrulatus scorpion venom in the rat. Toxicon 31: 1207–1210.
Mathur, A., G. Verma, R.S. Gehlot, and J.S. Ujjwal. 1993. Non-cardiac pulmonary oedema in scorpion bite. Journal of the Association of Physicians of India 41: 398.
Magalhaes, M.M., M.E. Pereira, C.F. Amaral, N.A. Rezende, D. Campolina, F. Bucaretchi, et al. 1999. Serum levels of cytokines in patients envenomed by Tityus serrulatus scorpion sting. Toxicon 37: 1155–1164.
Meki, A.R., and Z.M. Mohey El-Dean. 1998. Serum interleukin-1beta, interleukin-6, nitric oxide and alpha1-antitrypsin in scorpion envenomed children. Toxicon 36: 1851–1859.
Adi-Bessalem, S., A. Mendil, D. Hammoudi-Triki, and F. Laraba-Djebari. 2012. Lung immunoreactivity and airway inflammation: their assessment after scorpion envenomation. Inflammation 35: 501–508.
Raouraoua-Boukari, R., S. Sami-Merah, D. Hammoudi-Triki, M.F. Martin-Eauclaire, and F. Laraba-Djebari. 2012. Immunomodulation of the inflammatory response induced by Androctonus australis hector neurotoxins: biomarker interactions. Neuroimmunomodulation 19: 103–110.
Fukuhara, Y.D., R. Dellalibera-Joviliano, F.Q. Cunha, M.L. Reis, and E.A. Donadi. 2004. The kinin system in the envenomation caused by the Tityus serrulatus scorpion sting. Toxicology and Applied Pharmacology 196: 390–395.
Meki, A.R.M.A., and H.E. Omar. 1997. A bradykinin potentiating fraction isolated from the venom of Egyptian scorpion Buthus occitanus induced prostaglandin biosynthesis in female guinea pigs. Comparative Biochemistry and Physiology C-Pharmacology Toxicology and Endocrinology 116: 183–189.
Toll, L., and R.G. Almquist. 1986. Inhibition of [H-3] captopril binding by peptide analogue angiotensin converting enzyme-inhibitors. Biochemical and Biophysical Research Communications 135: 770–777.
Bhoola, K.D., C.D. Figueroa, and K. Worthy. 1992. Bioregulation of Kinins - Kallikreins, Kininogens, and Kininases. Pharmacological Reviews 44: 1–80.
Martin, M.F., and H. Rochat. 1986. Large scale purification of toxins from the venom of the scorpion Androctonus australis Hector. Toxicon 24: 1131–1139.
Deshpande, S.B., S. Bagchi, O.P. Rai, and N.C. Aryya. 1999. Pulmonary oedema produced by scorpion venom augments a phenyldiguanide-induced reflex response in anaesthetized rats. Journal of Physiology (London) 521: 537–544.
VanOosterhout, A.J.M., I. vanArk, G. Hofman, H.J. VanderLinde, D. Fattah, and F.P. Nijkamp. 1996. Role of interleukin-5 and substance P in development of airway hyperreactivity to histamine in guinea-pigs. European Respiratory Journal 9: 493–499.
Ergun, Y., E.B. Kurutas, B. Ozdil, R. Gunesacar, and Y. Ergun. 2011. Evaluation of nitrite/nitrate levels in relation to oxidative stress parameters in liver cirrhosis. Clinics and Research in Hepatology and Gastroenterology 35: 303–308.
Ohkawa, H., N. Ohishi, and K. Yagi. 1979. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Analytical Biochemistry 95: 351–358.
Aebi, H. 1984. Catalase Invitro. Methods in Enzymology 105: 121–126.
Adi-Bessalem, S., D. Hammoudi-Triki, and F. Laraba-Djebari. 2008. Pathophysiological effects of Androctonus australis hector scorpion venom: tissue damages and inflammatory response. Experimental and Toxicologic Pathology 60: 373–380.
Kimura, H., T. Sawada, S. Oshima, K. Kozawa, T. Ishioka, and M. Kato. 2005. Toxicity and roles of reactive oxygen species. Current Drug Targets. Inflammation and Allergy 4: 489–495.
Lardinois, O.M., M.M. Mestdagh, and P.G. Rouxhet. 1996. Reversible inhibition and irreversible inactivation of catalase in presence of hydrogen peroxide. Biochimica et Biophysica Acta 1295: 222–238.
Kanoo, S., and S.B. Deshpande. 2008. Involvement of phospholipase A2 pathway for the Indian red scorpion venom-induced augmentation of cardiopulmonary reflexes elicited by phenyldiguanide. Neuroscience Letters 440: 242–245.
Kanoo, S., A.B. Alex, A.K. Tiwari, and S.B. Deshpande. 2009. B(2) kinin receptors mediate the Indian red scorpion venom-induced augmentation of visceral reflexes via the nitric oxide cyclic guanosine monophosphate pathway. Acta Physiologica (Oxford, England) 196: 365–373.
Saidi, H., S. Adi-Bessalem, D. Hammoudi-Triki, and F. Laraba-Djebari. 2013. Effects of atropine and propranolol on lung inflammation in experimental envenomation: comparison of two buthidae venoms. Journal of Venomous Animals and Toxins Including Tropical Diseases 19: 8.
Abroug, F., R. Boujdaria, M. Belghith, S. Nouira, and S. Bouchoucha. 1991. Cardiac dysfunction and pulmonary edema following scorpion envenomation. Chest 100: 1057–1059.
Guillen, I., M. Blanes, M.J. Gomez-Lechon, and J.V. Castell. 1995. Cytokine signaling during myocardial infarction: sequential appearance of IL-1 beta and IL-6. American Journal of Physiology 269: R229–R235.
Faccioli, L.H., G.E. Souza, F.Q. Cunha, S. Poole, and S.H. Ferreira. 1990. Recombinant interleukin-1 and tumor necrosis factor induce neutrophil migration “in vivo” by indirect mechanisms. Agents and Actions 30: 344–349.
Baumann, H., and J. Gauldie. 1994. The acute phase response. Immunology Today 15: 74–80.
Fukuhara, Y.D., M.L. Reis, R. Dellalibera-Joviliano, F.Q. Cunha, and E.A. Donadi. 2003. Increased plasma levels of IL-1beta, IL-6, IL-8, IL-10 and TNF-alpha in patients moderately or severely envenomed by Tityus serrulatus scorpion sting. Toxicon 41: 49–55.
Abraham, E. 2000. Coagulation abnormalities in acute lung injury and sepsis. American Journal of Respiratory Cell and Molecular Biology 22: 401–404.
Moraes, T.J., C.W. Chow, and G.P. Downey. 2003. Proteases and lung injury. Critical Care Medicine 31: S189–S194.
Bekheet, S.H., E.A. Awadalla, M.M. Salman, and M.K. Hassan. 2013. Prevention of hepatic and renal toxicity with bradykinin potentiating factor (BPF) isolated from Egyptian scorpion venom (Buthus occitanus) in gentamicin treated rats. Tissue and Cell 45: 89–94.
Sandhya, P., and P. Varalakshmi. 1997. Effect of lipoic acid administration on gentamicin-induced lipid peroxidation in rats. Journal of Applied Toxicology 17: 405–408.
Lamraoui, A., S. Adi-Bessalem, and F. Laraba-Djebari. 2014. Modulation of tissue inflammatory response by histamine receptors in scorpion envenomation pathogenesis: involvement of H4 receptor. Inflammation 37: 1689–1704.
Bagchi, S., and S.B. Deshpande. 1998. Indian red scorpion (Buthus tamulus) venom-induced augmentation of cardiac reflexes is mediated through the mechanisms involving kinins in urethane anaesthetized rats. Toxicon 36: 309–320.
Ismail, M., A.J. Fatani, and T.T. Dabees. 1992. Experimental treatment protocols for scorpion envenomation: a review of common therapies and an effect of kallikrein-kinin inhibitors. Toxicon 30: 1257–1279.
Krishnan, A., R.V. Sonawane, and D.R. Karnad. 2007. Captopril in the treatment of cardiovascular manifestations of Indian red scorpion (Mesobuthus tamulus concanesis Pocock) envenomation. Journal of the Association of Physicians of India 55: 22–26.
Linardi, A., S.K. Costa, G.R. da Silva, and E. Antunes. 2000. Involvement of kinins, mast cells and sensory neurons in the plasma exudation and paw oedema induced by staphylococcal enterotoxin B in the mouse. European Journal of Pharmacology 399: 235–242.
Dutta, A., and S.B. Deshpande. 2011. Indian red scorpion venom-induced augmentation of cardio-respiratory reflexes and pulmonary edema involve the release of histamine. Toxicon 57: 193–198.
Buckley, I.K., and G.B. Ryan. 1969. Increased vascular permeability. The effect of histamine and serotonin on rat mesenteric blood vessels in vivo. American Journal of Pathology 55: 329–347.
Wachtfogel, Y.T., U. Kucich, C.E. Hack, P. Gluszko, S. Niewiarowski, R.W. Colman, et al. 1993. Aprotinin inhibits the contact, neutrophil, and platelet activation systems during simulated extracorporeal perfusion. Journal of Thoracic and Cardiovascular Surgery 106: 1–9. discussion 9-10.
Asimakopoulos, G., K.M. Taylor, D.O. Haskard, and R.C. Landis. 2000. Inhibition of neutrophil L-selectin shedding: a potential anti-inflammatory effect of aprotinin. Perfusion 15: 495–499.
Rhaleb, N.E., N. Rouissi, D. Jukic, D. Regoli, S. Henke, G. Breipohl, et al. 1992. Pharmacological characterization of a new highly potent B2 receptor antagonist (HOE 140: D-Arg-[Hyp3, Thi5, D-Tic7, Qic8] bradykinin). European Journal of Pharmacology 210: 115–120.
Liebmann, C., S. Nawrath, B. Ludwig, and I. Paegelow. 1993. Pharmacological and molecular actions of the bradykinin B2 receptor antagonist, Hoe 140, in the rat uterus. European Journal of Pharmacology 235: 183–188.
Freire-Maia, L., H.O. Almeida, J.R. Cunha-Melo, A.D. Azevedo, and J. Barroso. 1978. Mechanism of the pulmonary edema induced by intravenous injection of scorpion toxin in the rat. Agents and Actions 8: 113–118.
Bockmann, S., and I. Paegelow. 2000. Kinins and kinin receptors: importance for the activation of leukocytes. Journal of Leukocyte Biology 68: 587–592.
Blaukat, A. 2003. Structure and signalling pathways of kinin receptors. Andrologia 35: 17–23.
Ferreira, S.H., and M. Rocha et Silva. 1965. Potentiation of bradykinin and eledoisin by BPF (bradykinin potentiating factor) from Bothrops jararaca venom. Experientia 21: 347–349.
Stewart, J.M., S.H. Ferreira, and L.J. Greene. 1971. Bradykinin potentiating peptide PCA-Lys-Trp-Ala-Pro. An inhibitor of the pulmonary inactivation of bradykinin and conversion of angiotensin I to II. Biochemical Pharmacology 20: 1557–1567.
Cushman, D.W., H.S. Cheung, E.F. Sabo, B. Rubin, and M.A. Ondetti. 1979. Development of specific inhibitors of angiotensin I converting enzyme (kininase II). Federation Proceedings 38: 2778–2782.
Cushman, D.W., and M.A. Ondetti. 1980. Inhibitors of angiotensin-converting enzyme for treatment of hypertension. Biochemical Pharmacology 29: 1871–1877.
Erdos, E.G. 1975. Angiotensin I converting enzyme. Circulation Research 36: 247–255.
Togo, J., R.M. Burch, C.J. DeHaas, J.R. Connor, and L.R. Steranka. 1989. D-Phe7-substituted peptide bradykinin antagonists are not substrates for kininase II. Peptides 10: 109–112.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Medjadba, W., Martin-Eauclaire, MF. & Laraba-Djebari, F. Involvement of Kallikrein-Kinin System on Cardiopulmonary Alterations and Inflammatory Response Induced by Purified Aah I Toxin from Scorpion Venom. Inflammation 39, 290–302 (2016). https://doi.org/10.1007/s10753-015-0249-3
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10753-015-0249-3